Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis

被引:0
|
作者
Paul Harasymowycz
Cindy Hutnik
Jean-François Rouland
Francisco J. Muñoz Negrete
Mario A. Economou
Philippe Denis
Christophe Baudouin
机构
[1] University of Montreal,Ivey Eye Institute
[2] Bellevue Ophthalmology Clinics and Montreal Glaucoma Institute,Ophthalmology Department
[3] Western University,Department of Ophthalmology
[4] University of Lille,undefined
[5] Hospital Ramón y Cajal,undefined
[6] Universidad Alcalá,undefined
[7] Ophthalmology,undefined
[8] Queen Sofia Hospital,undefined
[9] Praktikertjänst,undefined
[10] HEH,undefined
[11] Hospices Civils de Lyon,undefined
[12] Quinze-Vingts National Ophthalmology Hospital,undefined
来源
Advances in Therapy | 2021年 / 38卷
关键词
Open-angle glaucoma; Ocular hypertension; Hyperemia; Ocular surface disease; Intraocular pressure; Latanoprost; Preservative-free; Monoprost; Patient satisfaction;
D O I
暂无
中图分类号
学科分类号
摘要
Preservatives in eye drops for glaucoma can cause side effects such as stinging and eye redness. These side effects can cause some patients to reduce the frequency of the drops as prescribed or stop using the drops. One of the most common drops for glaucoma is latanoprost. This study evaluated whether a preservative-free latanoprost (PFL) is as effective as preservative-containing latanoprost (PCL) for reducing eye pressure and whether PFL is better tolerated in patients with glaucoma. The results of the study indicated that PFL was as effective as PCL for reducing eye pressure. The results also indicated PFL was much better at reducing the side effects related to PCL. For example PFL reduces eye redness up to twofold compared to PCL. By reducing the side effects associated with PCL patients may continue to take their glaucoma drops as directed and thereby reduce the risk of vision loss from glaucoma.
引用
收藏
页码:3019 / 3031
页数:12
相关论文
共 50 条
  • [32] Corneal damage and its recovery after instillation of preservative-free versus preserved latanoprost eye drops
    Inoue, Daisuke
    Mohamed, Yasser Helmy
    Uematsu, Masafumi
    Kitaoka, Takashi
    CUTANEOUS AND OCULAR TOXICOLOGY, 2020, 39 (02) : 158 - 164
  • [33] Latanoprost in the treatment of glaucoma and ocular hypertension
    Watson, PG
    DRUGS OF TODAY, 1999, 35 (06) : 449 - 459
  • [34] Efficacy and safety of newly developed preservative-free latanoprost 0.005% eye drops versus preserved latanoprost 0.005% in open angle glaucoma and ocular hypertension: 12-week results of a randomized, multicenter, controlled phase III trial
    Kim, Joon Mo
    Sung, Kyung Rim
    Lee, Ji Woong
    Kyung, Haksu
    Rho, Seungsoo
    Kim, Chan Yun
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2021, 14 (10) : 1539 - 1547
  • [35] Ocular Surface Disease in Glaucoma Patients Randomized to Benzalkonium Chloride-Containing Latanoprost and Preservative-Free Bimatoprost
    Wu, Jo-Hsuan
    Wang, Tsing-Hong
    Huang, Jehn-Yu
    Su, Chien-Chia
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2021, 37 (10) : 556 - 564
  • [36] Ocular symptoms and signs with preserved and preservative-free glaucoma medications (vol 17, pg 341, 2007)
    Jaenen, N.
    Baudouin, C.
    Pouliquen, R.
    Manni, G.
    Figueiredo, A.
    Zeyen, T.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2007, 17 (04) : 688 - 688
  • [37] Tear cytokine profile of glaucoma patients treated with preservative-free or preserved latanoprost (vol 15, pg 723, 2017)
    Martinez-de-la-Casa, Jose M.
    Perez-Bartolome, Francisco
    Urcelay, Elena
    Santiago, Jose L.
    Moreno-Montanes, Javier
    Arriola-Villalobos, Pedro
    Benitez-del-Castillo, Jose M.
    Garcia-Feijoo, Julian
    OCULAR SURFACE, 2018, 16 (02): : 270 - 270
  • [38] Ocular Tolerability of Preservative-Free Tafluprost and Latanoprost: in vitro and in vivo Comparative Study
    Esaki, Yoshihiko
    Shimazaki, Atsushi
    Pellinen, Pertti
    OPEN OPHTHALMOLOGY JOURNAL, 2016, 10 : 146 - 153
  • [39] Tafluprost: The First Preservative-Free Prostaglandin to Treat Open-Angle Glaucoma and Ocular Hypertension
    Swymer, Cory
    Neville, Michael W.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (11) : 1506 - 1510
  • [40] 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monotherapy
    Konstas, Anastasios-Georgios
    Boboridis, Konstadinos G.
    Kapis, Paraskevas
    Marinopoulos, Konstantinos
    Voudouragkaki, Irini C.
    Panayiotou, Dimitrios
    Mikropoulos, Dimitrios G.
    Pagkalidou, Eirini
    Haidich, Anna-Bettina
    Katsanos, Andreas
    Quaranta, Luciano
    ADVANCES IN THERAPY, 2017, 34 (01) : 221 - 235